Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Nasopharyngeal Carcinoma 1Lymphoma 1Carcinoma, Non-Small-Cell Lung 1Burkitt Lymphoma 1

Interventions

Dexamethasone 10Cyclophosphamide 9Cytarabine 7venetoclax 6Vincristine 6Methotrexate 5blinatumomab 4Prednisone 4Inotuzumab Ozogamicin 4Doxorubicin 4Rituximab 3prednylidene 2pegaspargase 2merphos 2dexamethasone acetate 2dexamethasone 21-phosphate 2deltacortene 2Mercaptopurine 2Etoposide 2Decitabine 2Calcium Dobesilate 2trametinib 1ruxolitinib 1olverembatinib 1ofatumumab 1nilotinib 1navitoclax 1fludarabine 1capivasertib 1azathiopurine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × Leyk × Clear all
NCT02538926 2018-11-14

Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

University of Washington

Phase 2 Withdrawn
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡